Fox Run Management’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$375K Sell
16,512
-9,286
-36% -$213K 0.06% 596
2026
Q1
$591K Sell
25,798
-35,855
-58% -$772K 0.1% 370
2025
Q4
$1.23M Buy
+61,653
New +$1.2M 0.19% 129
2025
Q2
Sell
-26,852
Closed -$487K 1034
2025
Q1
$487K Buy
26,852
+5,048
+23% +$90.5K 0.08% 509
2024
Q4
$378K Buy
+21,804
New +$419K 0.07% 533
2019
Q3
Sell
-10,834
Closed -$158K 460
2019
Q2
$158K Buy
+10,834
New +$154K 0.1% 388
2018
Q3
Sell
-22,081
Closed -$305K 696
2018
Q2
$305K Sell
22,081
-40,550
-65% -$608K 0.1% 428
2018
Q1
$1.04M Buy
+62,631
New +$967K 0.25% 70
2017
Q1
Sell
-19,500
Closed -$209K 662
2016
Q4
$209K Sell
19,500
-8,900
-31% -$93.4K 0.11% 418
2016
Q3
$312K Sell
28,400
-15,300
-35% -$179K 0.18% 238
2016
Q2
$460K Buy
43,700
+27,500
+170% +$325K 0.22% 152
2016
Q1
$204K Buy
+16,200
New +$178K 0.14% 340

Other funds holding INVA

Fox Run Management's INVA Position: Q2 2026 in Review

Fox Run Management reduced its Innoviva (INVA) stake by 36% in Q2 2026, selling an estimated $213K and leaving 16,512 shares worth $375K. The position accounts for 0.06% of the portfolio, ranked #596.

Fox Run Management first reported a position in INVA in Q1 2016 and has held it in 12 quarters since. The position peaked at $1.23M in Q4 2025. 308 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • Fox Run Management held 16,512 shares of Innoviva worth $375K as of Q2 2026.
  • Fox Run Management sold 9,286 Innoviva shares in Q2 2026, an estimated $213K.
  • Innoviva made up 0.06% of Fox Run Management's portfolio in Q2 2026, its #596 holding.
  • Fox Run Management first reported a position in Innoviva in Q1 2016 and has held it in 12 quarters since.
  • Fox Run Management's Innoviva position peaked at $1.23M in Q4 2025.
  • 308 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.